Tozlu S - Search Results

1

Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.

Girault I, Tozlu S, Lidereau R, Bièche I. Girault I, et al. Among authors: tozlu s. Clin Cancer Res. 2003 Oct 1;9(12):4415-22. Clin Cancer Res. 2003. PMID: 14555514

2

Prognostic value of uPA, PAI-1 and PAI-2 mRNA expression in primary breast cancer.

Spyratos F, Bouchet C, Tozlu S, Labroquere M, Vignaud S, Becette V, Lidereau R, Bieche I. Spyratos F, et al. Among authors: tozlu s. Anticancer Res. 2002 Sep-Oct;22(5):2997-3003. Anticancer Res. 2002. PMID: 12530032

3

Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.

Girault I, Lerebours F, Amarir S, Tozlu S, Tubiana-Hulin M, Lidereau R, Bièche I. Girault I, et al. Among authors: tozlu s. Clin Cancer Res. 2003 Apr;9(4):1259-66. Clin Cancer Res. 2003. PMID: 12684393

4

Prognostic value of ERBB family mRNA expression in breast carcinomas.

Bièche I, Onody P, Tozlu S, Driouch K, Vidaud M, Lidereau R. Bièche I, et al. Among authors: tozlu s. Int J Cancer. 2003 Sep 20;106(5):758-65. doi: 10.1002/ijc.11273. Int J Cancer. 2003. PMID: 12866037

5

Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression.

Bièche I, Tozlu S, Girault I, Onody P, Driouch K, Vidaud M, Lidereau R. Bièche I, et al. Among authors: tozlu s. Carcinogenesis. 2004 Mar;25(3):405-11. doi: 10.1093/carcin/bgh024. Epub 2003 Nov 21. Carcinogenesis. 2004. PMID: 14633660

6

Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma.

Bièche I, Girault I, Urbain E, Tozlu S, Lidereau R. Bièche I, et al. Among authors: tozlu s. Breast Cancer Res. 2004;6(3):R252-63. doi: 10.1186/bcr784. Epub 2004 Mar 26. Breast Cancer Res. 2004. PMID: 15084249 Free PMC article.

7

Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma.

Girault I, Andrieu C, Tozlu S, Spyratos F, Bièche I, Lidereau R. Girault I, et al. Among authors: tozlu s. Cancer Lett. 2004 Nov 8;215(1):101-12. doi: 10.1016/j.canlet.2004.05.006. Cancer Lett. 2004. PMID: 15374639

8

Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature.

Bièche I, Lerebours F, Tozlu S, Espie M, Marty M, Lidereau R. Bièche I, et al. Among authors: tozlu s. Clin Cancer Res. 2004 Oct 15;10(20):6789-95. doi: 10.1158/1078-0432.CCR-04-0306. Clin Cancer Res. 2004. PMID: 15501955

9

Identification of a three-gene expression signature of poor-prognosis breast carcinoma.

Bièche I, Tozlu S, Girault I, Lidereau R. Bièche I, et al. Among authors: tozlu s. Mol Cancer. 2004 Dec 20;3(1):37. doi: 10.1186/1476-4598-3-37. Mol Cancer. 2004. PMID: 15606925 Free PMC article.

10

Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay.

Bièche I, Laurendeau I, Tozlu S, Olivi M, Vidaud D, Lidereau R, Vidaud M. Bièche I, et al. Among authors: tozlu s. Cancer Res. 1999 Jun 15;59(12):2759-65. Cancer Res. 1999. PMID: 10383126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters